Connections Shenzhen Chipscreen Biosciences Co., Ltd.

Shenzhen Chipscreen Biosciences Co Ltd is a China-based company primarily engaged in the research, development, production and sales of original innovative pharmaceuticals. The products primarily include the epigenetic regulator Epidaza (chidamide), the insulin sensitizer Bilessglu (chiglitazar), the triple-pathway tumor inhibitor chiauranib, the small-molecule PD-L1 inhibitor CS23546, the brain-penetrating Aurora B selective inhibitor CS231295 and the highly selective small-molecule allosteric inhibitor CS32582 for tyrosine kinase 2 (TYK2). The Company is also engaged in the development of drugs such as CS1011, CS08399 and CS25141, as well as the licensing of research and development technologies. The Company primarily operates its businesses in the domestic market and overseas markets, including the United States.